Oesophageal Cancer Trial, Recruiting NCT06169163 Sponsor: Imperial College London Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Oesophageal Cancer Trial, Recruiting

NCT06169163
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been newly diagnosed with a type of oesophageal (food pipe) cancer called squamous cell carcinoma, confirmed by a tissue biopsy, and have not yet received any treatment for it.
  • People who have recently had or are currently having a camera examination of the upper digestive tract (a procedure to look inside the throat, stomach, and upper gut) and were found to have either a healthy upper digestive tract or a non-cancerous condition of the upper digestive tract.

Who may not be able to join:

  • People who have already received any treatment for their oesophageal squamous cell carcinoma, such as chemotherapy, radiotherapy, immunotherapy, surgery, or an endoscopic procedure to remove tissue.
  • People who have been diagnosed with another type of cancer within the last five years.
  • People whose oesophageal (food pipe) cancer is not the squamous cell type.
  • People who have a condition called Barrett's oesophagus, which involves changes to the lining of the food pipe, whether or not it has progressed further.
  • People who have previously had surgery to remove part or all of their food pipe or stomach.
  • People who are unable to give written consent or do not have the capacity to agree to participate.
  • People who are pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 07576583519

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 December 2023
Est. completion
30 November 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

To develop a breath test for detection of OSCC

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov